Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway

Riccardo Alessandro, Maria Antonietta Di Bella, Pablo Reclusa Asiain, Marco Giallombardo, Simona Taverna, Marzia Pucci, Mariacarmela Santarpia, Ignacio Gil-Bazo, Simona Taverna, Pablo Reclusa, Christian Rolfo, Riccardo Alessandro

Risultato della ricerca: Article

28 Citazioni (Scopus)

Abstract

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths worldwide. The majority of patients are diagnosed in advanced disease stage. Bone metastasis is the most frequent complication in NSCLC resulting in osteolytic lesions. The perfect balance between bone-resorbing osteoclasts and bone-forming osteoblasts activity is lost in bone metastasis, inducing osteoclastogenesis. In NSCLC, the epidermal growth factor receptor (EGFR) pathway is constitutively activated. EGFR binds Amphiregulin (AREG) that is overexpressed in several cancers such as colon, breast and lung. Its levels in plasma of NSCLC patients correlate with poor prognosis and AREG was recently found as a signaling molecule in exosomes derived from cancer cell lines. Exosomes have a key role in the cell-cell communication and they were recently indicated as important actors in metastatic niche preparation. In the present work, we hypothesize a role of AREG carried by exosomes derived from NSCLC in bone metastasis induction. We observed that NSCLC-exosomes, containing AREG, induce EGFR pathway activation in pre-osteoclasts that in turn causes an increased expression of RANKL. RANKL is able to induce the expression of proteolytic enzymes, well-known markers of osteoclastogenesis, triggering a vicious cycle in osteolytic bone metastasis.
Lingua originaleEnglish
pagine (da-a)3170-
Numero di pagine14
RivistaScientific Reports
Volume7
Stato di pubblicazionePublished - 2017

Fingerprint

Exosomes
Osteoclasts
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Bone and Bones
Neoplasm Metastasis
Osteogenesis
Bone Neoplasms
Neoplasms
Osteoblasts
Cell Communication
Amphiregulin
Colon
Breast
Peptide Hydrolases
Cell Line
Lung

All Science Journal Classification (ASJC) codes

  • General

Cita questo

Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway. / Alessandro, Riccardo; Di Bella, Maria Antonietta; Reclusa Asiain, Pablo; Giallombardo, Marco; Taverna, Simona; Pucci, Marzia; Santarpia, Mariacarmela; Gil-Bazo, Ignacio; Taverna, Simona; Reclusa, Pablo; Rolfo, Christian; Alessandro, Riccardo.

In: Scientific Reports, Vol. 7, 2017, pag. 3170-.

Risultato della ricerca: Article

@article{6effc7f4dbad4899879463bdd0986ab3,
title = "Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway",
abstract = "Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths worldwide. The majority of patients are diagnosed in advanced disease stage. Bone metastasis is the most frequent complication in NSCLC resulting in osteolytic lesions. The perfect balance between bone-resorbing osteoclasts and bone-forming osteoblasts activity is lost in bone metastasis, inducing osteoclastogenesis. In NSCLC, the epidermal growth factor receptor (EGFR) pathway is constitutively activated. EGFR binds Amphiregulin (AREG) that is overexpressed in several cancers such as colon, breast and lung. Its levels in plasma of NSCLC patients correlate with poor prognosis and AREG was recently found as a signaling molecule in exosomes derived from cancer cell lines. Exosomes have a key role in the cell-cell communication and they were recently indicated as important actors in metastatic niche preparation. In the present work, we hypothesize a role of AREG carried by exosomes derived from NSCLC in bone metastasis induction. We observed that NSCLC-exosomes, containing AREG, induce EGFR pathway activation in pre-osteoclasts that in turn causes an increased expression of RANKL. RANKL is able to induce the expression of proteolytic enzymes, well-known markers of osteoclastogenesis, triggering a vicious cycle in osteolytic bone metastasis.",
author = "Riccardo Alessandro and {Di Bella}, {Maria Antonietta} and {Reclusa Asiain}, Pablo and Marco Giallombardo and Simona Taverna and Marzia Pucci and Mariacarmela Santarpia and Ignacio Gil-Bazo and Simona Taverna and Pablo Reclusa and Christian Rolfo and Riccardo Alessandro",
year = "2017",
language = "English",
volume = "7",
pages = "3170--",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway

AU - Alessandro, Riccardo

AU - Di Bella, Maria Antonietta

AU - Reclusa Asiain, Pablo

AU - Giallombardo, Marco

AU - Taverna, Simona

AU - Pucci, Marzia

AU - Santarpia, Mariacarmela

AU - Gil-Bazo, Ignacio

AU - Taverna, Simona

AU - Reclusa, Pablo

AU - Rolfo, Christian

AU - Alessandro, Riccardo

PY - 2017

Y1 - 2017

N2 - Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths worldwide. The majority of patients are diagnosed in advanced disease stage. Bone metastasis is the most frequent complication in NSCLC resulting in osteolytic lesions. The perfect balance between bone-resorbing osteoclasts and bone-forming osteoblasts activity is lost in bone metastasis, inducing osteoclastogenesis. In NSCLC, the epidermal growth factor receptor (EGFR) pathway is constitutively activated. EGFR binds Amphiregulin (AREG) that is overexpressed in several cancers such as colon, breast and lung. Its levels in plasma of NSCLC patients correlate with poor prognosis and AREG was recently found as a signaling molecule in exosomes derived from cancer cell lines. Exosomes have a key role in the cell-cell communication and they were recently indicated as important actors in metastatic niche preparation. In the present work, we hypothesize a role of AREG carried by exosomes derived from NSCLC in bone metastasis induction. We observed that NSCLC-exosomes, containing AREG, induce EGFR pathway activation in pre-osteoclasts that in turn causes an increased expression of RANKL. RANKL is able to induce the expression of proteolytic enzymes, well-known markers of osteoclastogenesis, triggering a vicious cycle in osteolytic bone metastasis.

AB - Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths worldwide. The majority of patients are diagnosed in advanced disease stage. Bone metastasis is the most frequent complication in NSCLC resulting in osteolytic lesions. The perfect balance between bone-resorbing osteoclasts and bone-forming osteoblasts activity is lost in bone metastasis, inducing osteoclastogenesis. In NSCLC, the epidermal growth factor receptor (EGFR) pathway is constitutively activated. EGFR binds Amphiregulin (AREG) that is overexpressed in several cancers such as colon, breast and lung. Its levels in plasma of NSCLC patients correlate with poor prognosis and AREG was recently found as a signaling molecule in exosomes derived from cancer cell lines. Exosomes have a key role in the cell-cell communication and they were recently indicated as important actors in metastatic niche preparation. In the present work, we hypothesize a role of AREG carried by exosomes derived from NSCLC in bone metastasis induction. We observed that NSCLC-exosomes, containing AREG, induce EGFR pathway activation in pre-osteoclasts that in turn causes an increased expression of RANKL. RANKL is able to induce the expression of proteolytic enzymes, well-known markers of osteoclastogenesis, triggering a vicious cycle in osteolytic bone metastasis.

UR - http://hdl.handle.net/10447/238077

UR - http://www.nature.com/srep/index.html

M3 - Article

VL - 7

SP - 3170-

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

ER -